Business
Electromedical Technologies, Inc. Reports Third Quarter 2021 Financial Results
Electromedical Technologies, Inc. Reports Third Quarter 2021 Financial Results.
About this update from Electromedical Technologies, Inc.
[{"type":"text","content":"\n\n\n\nElectromedical Technologies, Inc. Reports Third Quarter 2021 Financial Results\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nElectromedical Technologies, Inc. Reports Third Quarter 2021 Financial Results\nPR Newswire\nSCOTTSDALE, Ariz., Nov. 18, 2021\n\n\n\nQ3 2021 revenue increased $95,307, a roughly 46% increase over Q3 2020. $1.6M of variable convertible debt converted and settled in the nine months ended September 30, 2021. SCOTTSDALE, Ariz., Nov. 18, 2021 /PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) (the \"Company\"), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable, and acute pain by using frequencies and electro-modulation, is pleased to announce that it recorded positive results for the third quarter of 2021, ending September 30, as compared to the same period in 2020. The Company's Form 10-Q may be viewed on the Company's SEC Edgar page located here: https://www.sec.gov/ix?doc=/Archives/edgar/data/1715819/000141057821000301/elcq-20210930x10q.htm.\nMatthew Wolfson, Founder and CEO of EMED, noted, \"We are pleased with our positive operating results for the third quarter of 2021. Implementation of our new sales and marketing initiatives are starting to pay off, as indicated by the increases in both unit sales and revenue. We will continue to emphasize these initiatives going forward, which could provide an enhanced foundation for our outreach efforts, potentially resulting in repeat orders from our partners and distributors.\"\n\"Separately, as year-end approaches, we plan to update shareholders regarding our progress with the development of the WellnessPro POD, which is a critical pending milestone for EMED.\" Wearable technology has been rapidly developing in recent years. This is because more people are becoming conscious of their health and are pursuing a healthier drug free, pain free lifestyle. The WellnessPro POD will fit that criteria perfectly. In addition, it will be more affordable, which will help reach a larger segment of the population in need of chron...